Efficacy and safety of venetoclax in patients with relapsed/refractory multiple myeloma: a meta-analysis

被引：0
作者：
Xiaohui Gao
Hui Zeng
Xiaoyan Zhao
Haibing Wu
Minchao Yan
Yuan Li
Gang Zhang
Fei Sun
机构：
[1] The Affiliated Hospital of Jiaxing University,Departments of Pediatrics
[2] The Affiliated Hospital of Jiaxing University,Departments of Hematology
来源：
BMC Cancer | / 23卷
关键词：
Venetoclax; Multiple Myeloma; Efficacy; Adverse events; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
[21]   Safety and efficacy of daratumumab in combination with bortezomib and dexamethasone in Japanese patients with relapsed or refractory multiple myeloma [J].
Iida, Shinsuke ;
Ichinohe, Tatsuo ;
Shinagawa, Atsushi ;
Suzuki, Kenshi ;
Takezako, Naoki ;
Aoki, Masayuki .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2018, 107 (04) :460-467
[22]   Safety and efficacy of daratumumab in combination with bortezomib and dexamethasone in Japanese patients with relapsed or refractory multiple myeloma [J].
Shinsuke Iida ;
Tatsuo Ichinohe ;
Atsushi Shinagawa ;
Kenshi Suzuki ;
Naoki Takezako ;
Masayuki Aoki .
International Journal of Hematology, 2018, 107 :460-467
[23]   A single-center retrospective cohort analysis of venetoclax in relapsed/refractory multiple myeloma [J].
Kambhampati, Swetha ;
Galligan, Derek ;
Huang, Chiung-Yu ;
Wong, Sandy ;
Wolf, Jeffrey ;
Martin, Thomas ;
Shah, Nina .
LEUKEMIA & LYMPHOMA, 2020, 61 (05) :1211-1219
[24]   Efficacy, safety, and cost of pomalidomide in relapsed and refractory multiple myeloma [J].
Gueneau, Pauline ;
Chretien, Marie-Lorraine ;
Cransac-Miet, Amelie ;
Aho, Ludwig Serge ;
Lafon, Ingrid ;
Favennec, Camille ;
Guy, Julien ;
Caillot, Denis ;
Boulin, Mathieu .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 100 (05) :518-525
[25]   Efficacy and toxicity of histone deacetylase inhibitors in relapsed/refractory multiple myeloma: Systematic review and meta-analysis of clinical trials [J].
Gao, Xiao ;
Shen, Lijing ;
Li, Xiang ;
Liu, Jiaying .
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 18 (02) :1057-1068
[26]   A comparison of the efficacy of immunomodulatory-free regimens in relapsed or refractory multiple myeloma: a network meta-analysis [J].
Weisel, Katja ;
Sonneveld, Pieter ;
Spencer, Andrew ;
Beksac, Meral ;
Rizzo, Maria ;
Xu, Yingxin ;
Fahrbach, Kyle ;
Gaudig, Maren ;
Slavcev, Mary ;
Dearden, Lindsay ;
Lam, Annette .
LEUKEMIA & LYMPHOMA, 2019, 60 (01) :151-162
[27]   Efficacy and safety of daratumumab for the treatment of refractory/relapsed multiple myeloma. A systematic review of meta-analyses [J].
Moustafa, Diala Alhaj ;
Shafei, Laila ;
Sulaiman, Ruba ;
Yassin, Mohamed A. ;
Abushanab, Dina ;
Algarabli, Yousef ;
Al-Badriyeh, Daoud .
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2025, 31 (02) :266-275
[28]   Effective venetoclax-based treatment in relapsed/refractory multiple myeloma patients with translocation t(6;14) [J].
Cegledi, Andrea ;
Csukly, Zoltan ;
Fekete, Monika ;
Kozma, Andras ;
Szemlaky, Zsuzsanna ;
Andrikovics, Hajnalka ;
Mikala, Gabor .
PATHOLOGY & ONCOLOGY RESEARCH, 2023, 29
[29]   Safety and efficacy of Elotuzumab combination therapy for patients with multiple myeloma: A systematic review and meta-analysis [J].
Noori, Maryam ;
Fayyaz, Farimah ;
Rezaei, Nima .
EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (03) :327-338
[30]   Treatment options for refractory/relapsed multiple myeloma: an updated evidence synthesis by network meta-analysis [J].
Luo, Xian-Wu ;
Du, Xue-Qing ;
Li, Jie-Li ;
Liu, Xiao-Ping ;
Meng, Xiang-Yu .
CANCER MANAGEMENT AND RESEARCH, 2018, 10 :2817-2823
12345